Crott, R.

patient cancer utility health treatment mapping qlq-c survival data sets radiotherapy group regression trial model value life-year 2.5 years qlq-c 30 scores sample eq -5d utilities progression difference breast result study quality effect eq -5d score eortc cost-effectiveness nsclc table radiotherapy-only group disutilitie resource qlq-c 30 algorithm glioblastoma method 2.5 error mapping algorithm ficient evaluation scale analysis validity function estimate resource use mapping function adjuvant treatment arms coef ficients glioblastoma multiforme oncology disease disutility version radiotherapy-only validation accuracy eq -5d values treatment arm hospitalization netherland chemotherapy temozolomide number breast cancer model canada cost-effectiveness analysis tariff breast cancer data center price follow-up observation progression-free life-year